A Study of MRG007 Combination Therapy for Advanced Colorectal Cancer

NCT07737600 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

316

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Colorectal Cancer

Interventions

DRUG: MRG007
DRUG: 5-Fluorouracil / Leucovorin Calcium
DRUG: Bevacizumab
DRUG: Oxaliplatin
DRUG: PD-1/VEGF antibody
DRUG: Capecitabine

Sponsor

Lepu Biopharma Co., Ltd.